Aglatimagene besadenovec
LuTK02
Phase 2 mab active
Quick answer
Aglatimagene besadenovec for Non Small Cell Lung Cancer is a Phase 2 program (mab) at Candel Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Candel Therapeutics
- Indication
- Non Small Cell Lung Cancer
- Phase
- Phase 2
- Modality
- mab
- Status
- active